Laura Brege
CIK 1365619 · EVP, Corporate Affairs · last filed 2026-06-01
Laura Brege is an EVP, Corporate Affairs who has filed 109 SEC Form 4 insider transactions across 11 companies since 2007. The most recent filing, for ACAD, was dated Jun 1, 2026. Across all open-market trades the lifetime net is −$16.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.73M
11
109
-$16.43M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACAD | Director | 23,202 | $21.09 | $489.3K | -$5.19M | 31 | 2026-06-01 |
| MIRM | Director | 15,703 | $99.34 | $1.56M | -$1.15M | 9 | 2025-09-12 |
| EWTX | Director | — | $34.83 | — | $0 | 4 | 2025-06-18 |
| PCRX | Director | 23,715 | $22.99 | $545.2K | -$1.24M | 20 | 2025-06-13 |
| PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Director | 0 | — | — | $0 | 7 | 2020-07-02 |
| DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Director | — | $15.50 | — | $0 | 7 | 2019-05-31 |
| ARATANA THERAPEUTICS, INC. (PETX) Delisted | Director | 13,500 | — | — | $0 | 5 | 2018-07-30 |
| DCTH | Director | 11,678 | $11.72 | $136.9K | $0 | 3 | 2014-07-09 |
| ONYX PHARMACEUTICALS INC (ONXX) Delisted | EVP, Corporate Affairs | 45,574 | — | — | -$8.85M | 20 | 2011-10-17 |
| ANGIOTECH PHARMACEUTICALS INC (ANPI) Delisted | Director | — | — | — | $0 | 2 | 2009-12-14 |
| ANGIOTECH PHARMACEUTICALS INC (JRT) Delisted | Director | — | — | — | $0 | 1 | 2008-12-10 |
Recent Filings
109 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-01 | ACAD | Mixed | +8,107 | $0 | EDGAR |
| 2025-09-12 | MIRM | Mixed | — | -$1.01M | EDGAR |
| 2025-06-18 | EWTX | Grant (A) | — | $0 | EDGAR |
| 2025-06-13 | PCRX | Grant (A) | +6,163 | $0 | EDGAR |
| 2025-06-05 | ACAD | Sell (S) | −14,446 | -$314.6K | EDGAR |
| 2025-06-02 | MIRM | Mixed | +5,703 | $0 | EDGAR |
| 2025-06-02 | ACAD | Mixed | +9,387 | $0 | EDGAR |
| 2024-08-19 | PCRX | Buy (P) | +1,000 | $12.8K | EDGAR |
| 2024-06-13 | PCRX | Grant (A) | +5,230 | $0 | EDGAR |
| 2024-06-12 | EWTX | Grant (A) | — | $0 | EDGAR |